Lilly to Participate in Wolfe Research Virtual Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Nov. 18, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Eli Lilly and Company (NYSE: LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Nov. 18, 2021. Key executives, including Jacob Van Naarden, CEO of Loxo Oncology, will engage in a fireside chat at 10:30 a.m. Eastern time. Investors can access the event via a live audio webcast on the company's investor website, with a replay available for 90 days afterward. Lilly is committed to improving global health through innovative medicines and community support, continuing a century-old mission.
Details
News Market Reaction – LLY
The recorded move for LLY in the trading session of this news was +0.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
INDIANAPOLIS, Nov. 9, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Thursday, Nov. 18, 2021. Jacob Van Naarden, CEO of Loxo Oncology at Lilly and president, Lilly Oncology; Mark Mintun, senior vice president, research and development – neuroscience, and president, Avid Radiopharmaceuticals; and David Hyman, M.D., chief medical officer, Lilly Oncology, will participate in a fireside chat at 10:30 a.m., Eastern time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY
Refer to:
Jordan Bishop; bishop_jordan@lilly.com; 317-473-5712 (Media)
Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-wolfe-research-virtual-healthcare-conference-301420070.html
SOURCE Eli Lilly and Company
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.